Epigral Board to Consider Q2 and H1 Financial Results on 2nd Nov'26
Epigral Ltd 路 Intimation 路 02 Nov 2026, 5:30 am
Epigral Board to Consider Q2 and H1 Financial Results on 2nd Nov'26 Epigral Limited has scheduled its Board of Directors meeting for 2nd Nov'26 to consider, approve, and take on record the standalone and consolidated unaudited financial results for the second quarter and half year ended 30th Sep'26. The board will also review the Statutory Auditors' Limited Review Report for the period, in compliance with Regulation 29 of SEBI LODR Regulations, 2015.
Original exchange filing (PDF)
More announcements from Epigral Ltd
- One-on-One Meeting through Video Conferencing (V.C.) with Kotak Mahindra Asset Management (Singapore) Pte Ltd on Thursday, 19th November, 2026. 路 18 Nov 2026
- One-on-One Meeting through Video Conferencing (V.C.) with Kitara Capital on Friday, 20th November, 2026. 路 18 Nov 2026
- Epigral Limited submits Transcript of conference call held on Monday, 2nd November, 2026 discussing Q2 FY2027 Results. 路 08 Nov 2026
- Audio Recording of Conference Call discussing Q2 FY27 Results held on Monday, 2nd November, 2026 at 5.00 P.M. 路 03 Nov 2026
- INVESTOR PRESENTATION - Q2 FY27. 路 02 Nov 2026
- PRESS RELEASE - RESULTS- Q2 FY27. 路 02 Nov 2026
- UNAUDITED FINANCIAL RESULTS - 30.09.2026 路 02 Nov 2026
- Epigral Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 02 Nov 2026
